ArticleEuropean radiology2014

Does tumoral (111)In-ibritumomab accumulation correlate with therapeutic effect and outcome in relapsed or refractory low-grade B-cell lymphoma patients undergoing (90)Y-ibritumomab radioimmunotherapy?

Koichiro Kaneko et al.PubMed ↗Publisher ↗

No numbers read from the abstract.